GRIMALDI CLAUDIA
SEC insider (Form 3/4/5 filer). CIK 0001745853. PFO at IGC Pharma, Inc. (IGC). 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 25, 2026. Located in POTOMAC, MD.
Companies GRIMALDI CLAUDIA has filed insider reports for
- IGC Pharma, Inc. (IGC): Director, Officer, PFO
GRIMALDI CLAUDIA
CIK: 0001745853
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)4 (44.4%)
Derivative conversions
Awards (A)3 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (22.2%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IGC
IGC Pharma, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 25, 2026IGC
IGC Pharma, Inc.
GiftDirect150K shares- - Jun 30, 2026IGC
IGC Pharma, Inc.
AwardDirect2M shares at avg. $0.27$553K - Apr 1, 2026IGC
IGC Pharma, Inc.
ExerciseDirect100K shares- - Apr 1, 2026IGC
IGC Pharma, Inc.
ExerciseDirect138.5K shares at avg. $0.26$36K - Oct 17, 2025IGC
IGC Pharma, Inc.
AwardDirectOptions
500K shares- - Oct 17, 2025IGC
IGC Pharma, Inc.
GiftDirect50K shares- - Oct 17, 2025IGC
IGC Pharma, Inc.
AwardDirectOptions
1M shares- - Mar 31, 2025IGC
IGC Pharma, Inc.
ExerciseDirect100K shares- - Mar 31, 2025IGC
IGC Pharma, Inc.
ExerciseDirect58.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 25, 2026 | IGC IGC Pharma, Inc. | Gift | 150,000 | - | $0 | Direct |
| Jun 30, 2026 | IGC IGC Pharma, Inc. | Award | 2,048,378 | $0.27 | $553,062 | Direct |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | Exercise | 100,000 | - | $0 | Direct |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | Exercise | 138,462 | $0.26 | $36,000 | Direct |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | Award Options | 500,000 | - | - | Direct |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | Gift | 50,000 | - | - | Direct |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | Award Options | 1,000,000 | - | - | Direct |
| Mar 31, 2025 | IGC IGC Pharma, Inc. | Exercise | 100,000 | - | - | Direct |
| Mar 31, 2025 | IGC IGC Pharma, Inc. | Exercise | 58,333 | - | - | Direct |
1-9 of 9 transactions